Evolent Health Company Profile (NYSE:EVH)

About Evolent Health (NYSE:EVH)

Evolent Health logoEvolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Symbol: NYSE:EVH
  • CUSIP: N/A
  • Web: www.evolenthealth.com
Capitalization:
  • Market Cap: $1.31736 billion
  • Outstanding Shares: 65,822,000
Average Prices:
  • 50 Day Moving Avg: $24.02
  • 200 Day Moving Avg: $22.70
  • 52 Week Range: $14.50 - $27.50
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: Infinity
  • P/E Growth: -1.40
Sales & Book Value:
  • Annual Revenue: $361.53 million
  • Price / Sales: 3.14
  • Book Value: $13.07 per share
  • Price / Book: 1.32
Profitability:
  • EBIDTA: ($51,150,000.00)
  • Net Margins: -17.57%
  • Return on Equity: -6.44%
  • Return on Assets: -5.13%
Debt:
  • Debt-to-Equity Ratio: 0.14%
  • Current Ratio: 1.89%
  • Quick Ratio: 1.89%
Misc:
  • Average Volume: 1.30 million shs.
  • Beta: 1.22
  • Short Ratio: 11.19
 
Frequently Asked Questions for Evolent Health (NYSE:EVH)

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health, Inc (NYSE:EVH) posted its quarterly earnings results on Monday, August, 7th. The company reported ($0.13) EPS for the quarter, meeting the consensus estimate of ($0.13). The firm earned $107.30 million during the quarter, compared to analysts' expectations of $104.45 million. Evolent Health had a negative return on equity of 6.44% and a negative net margin of 17.57%. The business's revenue for the quarter was up 89.9% on a year-over-year basis. During the same quarter last year, the firm earned ($0.20) earnings per share. View Evolent Health's Earnings History.

Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2017?

12 analysts have issued 12 month price targets for Evolent Health's shares. Their forecasts range from $26.00 to $35.00. On average, they expect Evolent Health's share price to reach $30.33 in the next year. View Analyst Ratings for Evolent Health.

What are analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:

  • 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (8/10/2017)
  • 2. Cantor Fitzgerald analysts commented, "4Q16 results were solid. Adjusted 4Q16 revenue of $90 million (+92.6% y/y) was above consensus expectations of $85.3 million. Revenue included contributions from Valence and Aldera. Revenue growth was driven by contributions from Valence and Aldera and by an increase in the number of lives on the company’s platform. The number of lives grew 181.5% y/y, reaching about 2.0 million lives in 4Q16. EVH also added another 600,000 lives to the platform in January 2017. Adjusted transformation revenue of $12.1 million increased 12% y/y. Transformation revenue can fluctuate quarter-to-quarter due to the timing of customer contracts and the scope of delivery. Adjusted platform and operation revenue of $77.9 million (+116.8%) benefited from an increased number of lives on the platform. Average PMPM was $12.87 in 4Q16 vs. $16.70." (3/1/2017)

Who are some of Evolent Health's key competitors?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:

  • Seth Blackley, President
  • Frank John Williams, Chief Executive Officer, Director
  • Nicholas P. McGrane, Chief Financial Officer
  • Thomas Peterson III, Chief Operating Officer
  • Charles W. Pomeroy Jr., Chief Technology Officer
  • Lydia Stone, Principal Accounting Officer, Corporate Controller
  • Jonathan D. Weinberg, General Counsel
  • Dave Thornton, Chief Talent Officer
  • Steven J. Wigginton, Chief Development Officer
  • David Farner, Director

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who owns Evolent Health stock?

Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (15.93%), JPMorgan Chase & Co. (8.78%), Vanguard Group Inc. (6.09%), Riverbridge Partners LLC (4.02%), Blair William & Co. IL (3.79%) and TimesSquare Capital Management LLC (2.43%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Institutional Ownership Trends for Evolent Health.

Who sold Evolent Health stock? Who is selling Evolent Health stock?

Evolent Health's stock was sold by a variety of institutional investors in the last quarter, including TPG Group Holdings SBS Advisors Inc., Marshall Wace North America L.P., Goldman Sachs Group Inc., Gilder Gagnon Howe & Co. LLC, Tygh Capital Management Inc., Peregrine Capital Management LLC, Elk Creek Partners LLC and Dowling & Yahnke LLC. Company insiders that have sold Evolent Health stock in the last year include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Insider Buying and Selling for Evolent Health.

Who bought Evolent Health stock? Who is buying Evolent Health stock?

Evolent Health's stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Riverbridge Partners LLC, Vanguard Group Inc., Eagle Asset Management Inc., Wells Fargo & Company MN, Castleark Management LLC, Sectoral Asset Management Inc and Russell Investments Group Ltd.. View Insider Buying and Selling for Evolent Health.

How do I buy Evolent Health stock?

Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of Evolent Health stock can currently be purchased for approximately $17.25.


MarketBeat Community Rating for Evolent Health (NYSE EVH)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  280
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Evolent Health (NYSE:EVH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 11 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.08)
Consensus Price Target: $30.33 (75.85% upside)

Analysts' Ratings History for Evolent Health (NYSE:EVH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/9/2017Cowen and CompanyReiterated RatingOutperform$35.00 -> $33.00HighView Rating Details
8/8/2017Robert W. BairdSet Price TargetBuy$35.00HighView Rating Details
6/19/2017Leerink SwannReiterated RatingOutperform$30.00 -> $32.00LowView Rating Details
4/13/2017Jefferies Group LLCReiterated RatingBuy$28.00LowView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformLowView Rating Details
3/13/2017Oppenheimer Holdings, Inc.Initiated CoverageOutperform$28.00LowView Rating Details
3/8/2017Goldman Sachs Group, Inc. (The)UpgradeBuy -> Conviction-Buy$30.00MediumView Rating Details
3/1/2017Cantor FitzgeraldReiterated RatingBuy$26.00N/AView Rating Details
2/3/2017Canaccord GenuityReiterated RatingBuy$31.00N/AView Rating Details
1/13/2017Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
10/28/2016J P Morgan Chase & CoInitiated CoverageOverweight$30.00N/AView Rating Details
9/30/2016William BlairReiterated RatingOutperformN/AView Rating Details
8/5/2016FBR & CoBoost Price TargetOutperform$24.00 -> $26.00N/AView Rating Details
(Data available from 8/17/2015 forward)

Earnings

Earnings History for Evolent Health (NYSE:EVH)
Earnings by Quarter for Evolent Health (NYSE:EVH)
Earnings History by Quarter for Evolent Health (NYSE EVH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2017Q2 2017($0.13)($0.13)$104.45 million$107.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.26)$104.38 million$106.80 millionViewListenView Earnings Details
2/28/2017Q416($0.20)($0.35)$84.98 million$88.00 millionViewListenView Earnings Details
11/9/2016Q316($0.13)($0.26)$58.35 million$60.20 millionViewListenView Earnings Details
8/4/2016Q216($0.16)($0.12)$51.96 million$56.50 millionViewN/AView Earnings Details
5/12/2016Q116($0.19)($0.16)$47.40 million$49.50 millionViewListenView Earnings Details
2/25/2016Q415($0.21)($0.05)$43.73 million$46.70 millionViewListenView Earnings Details
11/5/2015Q315($0.21)($0.16)$42.51 million$43.30 millionViewN/AView Earnings Details
8/6/2015Q215($0.37)($1.00)$157.50 million$36.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evolent Health (NYSE:EVH)
2017 EPS Consensus Estimate: ($0.24)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.11)($0.11)($0.11)
Q3 20172($0.07)($0.07)($0.07)
Q4 20173($0.09)($0.04)($0.06)
Q1 20181($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Evolent Health (NYSE:EVH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Evolent Health (NYSE:EVH)
Insider Ownership Percentage: 8.79%
Institutional Ownership Percentage: 68.08%
Insider Trades by Quarter for Evolent Health (NYSE:EVH)
Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)
Insider Trades by Quarter for Evolent Health (NYSE:EVH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/3/2017Frank J. WilliamsCEOSell16,300$23.73$386,799.00View SEC Filing  
8/1/2017Steve WiggintonCEOSell6,000$24.64$147,840.00View SEC Filing  
7/24/2017Thomas Peterson IIICOOSell40,540$26.00$1,054,040.00View SEC Filing  
7/10/2017Nicholas McgraneCFOSell1,667$25.42$42,375.14View SEC Filing  
7/6/2017Frank J. WilliamsCEOSell16,300$24.76$403,588.00View SEC Filing  
7/3/2017Steve WiggintonCEOSell6,000$25.07$150,420.00View SEC Filing  
6/28/2017Tpg Growth Ii Advisors, Inc.InsiderSell4,279,325$25.87$110,706,137.75View SEC Filing  
6/15/2017Seth BlackleyPresidentSell15,000$25.22$378,300.00View SEC Filing  
6/12/2017Nicholas McgraneCFOSell1,667$24.58$40,974.86View SEC Filing  
6/7/2017Nicholas McgraneCFOSell10,495$26.95$282,840.25View SEC Filing  
6/6/2017Kenneth A. SametDirectorSell4,000$25.75$103,000.00View SEC Filing  
6/6/2017Steve WiggintonCEOSell959$25.75$24,694.25View SEC Filing  
5/19/2017Cheryl ScottDirectorSell5,477$23.51$128,764.27View SEC Filing  
5/19/2017Frank J. WilliamsCEOSell114,865$24.30$2,791,219.50View SEC Filing  
5/19/2017Jonathan WeinbergGeneral CounselSell17,230$24.30$418,689.00View SEC Filing  
5/19/2017Nicholas McgraneCFOSell47,508$24.30$1,154,444.40View SEC Filing  
5/19/2017Thomas Peterson IIICOOSell57,433$24.30$1,395,621.90View SEC Filing  
5/19/2017Tpg Growth Ii Advisors, Inc.InsiderSell3,081,760$24.30$74,886,768.00View SEC Filing  
5/19/2017UpmcMajor ShareholderSell2,333,333$24.30$56,699,991.90View SEC Filing  
5/15/2017Seth BlackleyPresidentSell15,000$25.00$375,000.00View SEC Filing  
5/15/2017Thomas Peterson IIICOOSell83,108$24.99$2,076,868.92View SEC Filing  
5/10/2017Nicholas McgraneInsiderSell1,667$24.28$40,474.76View SEC Filing  
5/10/2017Thomas Peterson IIICOOSell18,604$25.00$465,100.00View SEC Filing  
5/4/2017Frank J WilliamsCEOSell16,300$23.55$383,865.00View SEC Filing  
5/3/2017Jonathan WeinbergGeneral CounselSell15,000$23.85$357,750.00View SEC Filing  
5/1/2017Steve WiggintonCEOSell6,000$23.10$138,600.00View SEC Filing  
5/1/2017UpmcMajor ShareholderSell403,644$19.53$7,883,167.32View SEC Filing  
4/19/2017Nicholas McgraneCFOSell1,667$22.52$37,540.84View SEC Filing  
4/17/2017Seth BlackleyPresidentSell15,000$21.48$322,200.00View SEC Filing  
4/6/2017Frank J WilliamsCEOSell16,300$22.03$359,089.00View SEC Filing  
4/3/2017Steve WiggintonCEOSell6,000$23.15$138,900.00View SEC Filing  
3/31/2017UpmcMajor ShareholderSell2,690,961$19.53$52,554,468.33View SEC Filing  
3/30/2017Seth BlackleyPresidentSell15,000$21.19$317,850.00View SEC Filing  
3/28/2017Board Co AdvisoryMajor ShareholderSell2,118,078$19.53$41,366,063.34View SEC Filing  
3/24/2017Nicholas McgraneCFOSell7,034$22.50$158,265.00View SEC Filing  
1/30/2017Seth BlackleyPresidentSell15,000$17.58$263,700.00View SEC Filing  
1/17/2017Seth BlackleyPresidentSell30,000$17.98$539,400.00View SEC Filing  
11/14/2016Michael D'amatoDirectorBuy10,000$17.18$171,800.00View SEC Filing  
9/22/2016Board Co AdvisoryMajor ShareholderSell317,712$22.50$7,148,520.00View SEC Filing  
9/14/2016Board Co AdvisoryMajor ShareholderSell1,936,529$22.50$43,571,902.50View SEC Filing  
9/14/2016Chad PomeroyInsiderSell55,180$21.54$1,188,577.20View SEC Filing  
9/14/2016Frank J WilliamsCEOSell251,481$21.54$5,416,900.74View SEC Filing  
9/14/2016Jonathan WeinbergGeneral CounselSell10,339$21.54$222,702.06View SEC Filing  
9/14/2016Nicholas McgraneCFOSell21,205$21.54$456,755.70View SEC Filing  
9/14/2016Seth BlackleyPresidentSell167,672$21.54$3,611,654.88View SEC Filing  
9/14/2016Thomas Peterson IIICOOSell72,827$21.54$1,568,693.58View SEC Filing  
6/10/2015Gary PieferInsiderBuy2,000$17.00$34,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Evolent Health (NYSE:EVH)
Latest Headlines for Evolent Health (NYSE:EVH)
Source:
DateHeadline
americanbankingnews.com logoQ3 2017 Earnings Estimate for Evolent Health, Inc Issued By William Blair (EVH)
www.americanbankingnews.com - August 17 at 8:22 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Evolent Health Inc.
finance.yahoo.com - August 12 at 5:43 PM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - August 12 at 3:34 PM
americanbankingnews.com logoFY2017 EPS Estimates for Evolent Health, Inc (EVH) Reduced by Oppenheimer Holdings
www.americanbankingnews.com - August 11 at 12:02 PM
americanbankingnews.com logoQ3 2017 EPS Estimates for Evolent Health, Inc (NYSE:EVH) Decreased by Analyst
www.americanbankingnews.com - August 11 at 9:34 AM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - August 10 at 7:46 PM
finance.yahoo.com logoEvolent Health, Inc. :EVH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017
finance.yahoo.com - August 10 at 7:45 PM
finance.yahoo.com logoEdited Transcript of EVH earnings conference call or presentation 7-Aug-17 9:00pm GMT
finance.yahoo.com - August 9 at 4:23 AM
finance.yahoo.com logoEvolent Health, Inc. Announces Pricing of Public Offering of Class A Common Stock
finance.yahoo.com - August 8 at 11:19 PM
seekingalpha.com logoEvolent Health's (EVH) CEO Frank Williams on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 8 at 6:15 PM
nasdaq.com logoOversold Conditions For Evolent Health (EVH) - Nasdaq
www.nasdaq.com - August 8 at 6:15 PM
finance.yahoo.com logoInvestor Network: Evolent Health Inc. to Host Earnings Call
finance.yahoo.com - August 8 at 6:15 PM
finance.yahoo.com logoEvolent Health stock falls on bigger loss, new stock offering
finance.yahoo.com - August 8 at 6:15 PM
fool.com logoWhy Evolent Health, Inc. Is Plunging Today
www.fool.com - August 8 at 1:32 PM
americanbankingnews.com logoEvolent Health, Inc (EVH) Given a $35.00 Price Target at Robert W. Baird
www.americanbankingnews.com - August 8 at 10:06 AM
prnewswire.com logoEvolent Health Announces Second Quarter 2017 Results - PR Newswire (press release)
www.prnewswire.com - August 8 at 4:46 AM
streetinsider.com logoEvolent Health (EVH) Plans $175M Offering of Class A Common Stock - StreetInsider.com
www.streetinsider.com - August 8 at 4:46 AM
americanbankingnews.com logoEvolent Health, Inc (EVH) Posts Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - August 7 at 9:16 PM
streetinsider.com logoEvolent Health (EVH) Plans $175M Offering of Class A Common Stock
www.streetinsider.com - August 7 at 6:42 PM
finance.yahoo.com logoEvolent Health Announces Second Quarter 2017 Results
finance.yahoo.com - August 7 at 6:42 PM
finance.yahoo.com logoEvolent Health Partners with Crystal Run Healthcare to Power Its New York-Based Provider-Sponsored Health Plan
finance.yahoo.com - August 7 at 6:42 PM
finance.yahoo.com logoEvolent Health, Inc. Announces Proposed Public Offering of Class A Common Stock
finance.yahoo.com - August 7 at 6:42 PM
finance.yahoo.com logoEvolent Health reports 2Q loss
finance.yahoo.com - August 7 at 6:42 PM
americanbankingnews.com logoHead-To-Head Contrast: Fluidigm Corporation (FLDM) vs. Evolent Health (EVH)
www.americanbankingnews.com - August 6 at 10:30 AM
americanbankingnews.com logoZacks: Analysts Expect Evolent Health, Inc (NYSE:EVH) Will Post Quarterly Sales of $104.54 Million
www.americanbankingnews.com - August 5 at 11:10 AM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 5 at 10:48 AM
americanbankingnews.com logoFrank J. Williams Sells 16,300 Shares of Evolent Health, Inc (NYSE:EVH) Stock
www.americanbankingnews.com - August 4 at 8:22 PM
americanbankingnews.com logoInsider Selling: Evolent Health, Inc (NYSE:EVH) CEO Sells 6,000 Shares of Stock
www.americanbankingnews.com - August 3 at 8:40 PM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) Expected to Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - August 3 at 8:08 AM
finance.yahoo.com logoEvolent Health, Inc. Announces Revised Second Quarter 2017 Operating Results and Conference Call Date
finance.yahoo.com - July 31 at 6:11 PM
finance.yahoo.com logoEvolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : July 28, 2017
finance.yahoo.com - July 28 at 4:32 PM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) COO Thomas Peterson III Sells 40,540 Shares
www.americanbankingnews.com - July 26 at 7:58 PM
americanbankingnews.com logoContrasting Fluidigm Corporation (FLDM) and Evolent Health (EVH)
www.americanbankingnews.com - July 26 at 8:32 AM
finance.yahoo.com logoEvolent Health, Inc. to Release Second Quarter 2017 Operating Results and Host Conference Call on Tuesday, August 8, 2017
finance.yahoo.com - July 25 at 6:42 PM
americanbankingnews.com logoHead-To-Head Analysis: Simulations Plus (SLP) vs. Evolent Health (NYSE:EVH)
www.americanbankingnews.com - July 21 at 12:06 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - July 16 at 3:22 PM
americanbankingnews.com logo$104.54 Million in Sales Expected for Evolent Health, Inc (EVH) This Quarter
www.americanbankingnews.com - July 13 at 10:00 AM
americanbankingnews.com logoNicholas Mcgrane Sells 1,667 Shares of Evolent Health, Inc (NYSE:EVH) Stock
www.americanbankingnews.com - July 12 at 8:45 PM
americanbankingnews.com logoEvolent Health, Inc (NYSE:EVH) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 11 at 10:48 AM
finance.yahoo.com logoEvolent Health, Inc. – Value Analysis (NYSE:EVH) : July 10, 2017
finance.yahoo.com - July 10 at 6:23 PM
finance.yahoo.com logoEvolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : July 7, 2017
finance.yahoo.com - July 8 at 10:38 AM
americanbankingnews.com logoSteve Wigginton Sells 6,000 Shares of Evolent Health, Inc (EVH) Stock
www.americanbankingnews.com - July 6 at 8:05 PM
americanbankingnews.com logoTpg Growth Ii Advisors, Inc. Sells 4,279,325 Shares of Evolent Health, Inc (EVH) Stock
www.americanbankingnews.com - June 30 at 7:16 PM
americanbankingnews.com logoEvolent Health's (EVH) "Outperform" Rating Reaffirmed at Cowen and Company
www.americanbankingnews.com - June 28 at 12:40 PM
benzinga.com logoWhat The Street Gets Wrong About Evolent Health, Cowen's 'Best Small-Mid Cap Idea' - Benzinga
www.benzinga.com - June 28 at 3:23 AM
rttnews.com logoEvolent Health (EVH) Is Heading Lower After Secondary Offering
www.rttnews.com - June 24 at 5:26 PM
nasdaq.com logoEvolent Health (EVH) Prices 4.5M Follow-On Share Offering - Nasdaq
www.nasdaq.com - June 23 at 5:42 PM
americanbankingnews.com logoSeth Blackley Sells 15,000 Shares of Evolent Health, Inc (EVH) Stock
www.americanbankingnews.com - June 19 at 7:35 PM
americanbankingnews.com logoEvolent Health's (EVH) "Outperform" Rating Reaffirmed at Leerink Swann
www.americanbankingnews.com - June 19 at 5:38 PM
streetinsider.com logoEvolent Health (EVH) PT Raised to $32 at Leerink Partners - StreetInsider.com
www.streetinsider.com - June 19 at 1:23 PM

Social

Chart

Evolent Health (EVH) Chart for Thursday, August, 17, 2017

This page was last updated on 8/17/2017 by MarketBeat.com Staff